Article
The BRCA1 exon 13 duplication: clinical characteristics of 22 families in Northern Sweden.
Familial cancer - 1 Jan 2019
Edwinsdotter Ardnor Christina, Rosén Anna, Ljuslinder Ingrid, Melin Beatrice
Abstract excerpt
The clinical management of BRCA1/2 mutation carriers requires accurate cancer risk estimates. Cancer risks vary according to type and location of the mutation and since there is limited information about mutation-specific cancer risks, genotype-phenotype correlation studies are needed. This is a report of 22 families with the same mutation, BRCA1 duplication exon 13, a mutation that is found world-wide, with the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
